Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished May 20, 2026 9:00 AM ・ Updated May 21, 2026 9:33 AM ・ 2 min read ・ Source: PR Times
Pell Bio-Medical announced that Deputy Head of R&D Lin Wei-Chi will resign for personal career planning, effective May 20, 2026. The role of Head of R&D will be temporarily assumed by Lin Ren-Jie, the current Director of the R&D Department.
1. Type of personnel change: Head of R&D 2. Date of change: 2026/05/20 3. Name, title, and brief resume of the former officer: Lin Wei-Chi / Deputy Head of R&D of the company 4. Name, title, and brief resume of the new officer: Lin Ren-Jie (Acting) / Director of the R&D Department of the company 5. Nature of the change: Resignation 6. Reason for the change: Personal career planning 7. Effective date: 2026/05/20 8. Other matters to be specified: None
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.